A two-step process designed to give investigators clear feedback fast — and to ensure approved projects get the methodological support they need to publish at the highest scientific bar.
A brief two-paragraph submission to the Board of Directors describing your hypothesis, proposal, and key data elements needed.
The CRF checks with Corrona, LLC to determine if there is any overlap or conflict with current or planned activities and priorities.
If approved, submit a 2-page proposal with hypothesis, methodology, novel insights, references, and projected timelines.
The Clinical Investigators Committee reviews and numerically rates the proposal. Accepted projects get biostatistics support from Dr. Reed.
Please read the CRF Publications, Presentations and Ancillary Study Proposals Guidelines before completing your full proposal.
A first step to submitting a proposal is a brief, 2-paragraph submission that describes:
The research question your project will address.
How you'll approach answering it.
What CRF data you need.
Lead author, institution, contact.
The CRF will check with Corrona, LLC to determine if there is any overlap or conflict with their current or planned activities. If no conflicts are identified, the submitter is notified of approval to proceed to Step 2.
Clearly defined, with the data elements required to address the topic.
Description of analytical outputs along with suggested methodological approach.
Projected timelines for completion and target ACR or EULAR meeting.
Anticipated support needed from CRF biostat professionals.
How the project expands existing knowledge.
Senior/junior investigators from CIC or the PI's institution.
Peer-reviewed publication intended for journals such as Arthritis & Rheumatology, ARD, Journal of Rheumatology.
Posters and oral presentations targeting ACR, EULAR, or other annual meetings.
Preliminary data for a peer-reviewed grant application from the PI and proposer's institution.
Open the submission form. Your work autosaves to your browser as you type, and you can save and continue later.